Skip to playerSkip to main content
  • 23 hours ago
The drug ketamine is set to be trialled in Australia to help treat emergency responders who continue to experience post traumatic stress disorder and depression after exhausting previous treatments. The black dog institute will run the clinical trial, combining the drug with exposure therapy. Ketamine was developed in the 1960's as a medical and veterinary anaesthetic and is now also used as a recreational drug. For more, let's hear from professor Sam Harvey who is the chief scientist at the black dog institute and Tara Lal who is a former emergency worker.

Category

📺
TV
Transcript
00:02So, in Australia, we ask a lot of our emergency service workers and we know large numbers,
00:08increasing numbers of them are developing problems like post-traumatic stress disorder.
00:12We've really been able to lead the world in Australia about how to treat PTSD through
00:17federal government funding. There's now a national treatment service for emergency service workers.
00:23But even with the best treatment, we know only about three quarters of them are able
00:27to recover. So, the reason we're excited about ketamine is because we think it holds hope
00:33for helping that 25% who don't get better with standard treatment.
00:38It's designed as an anaesthetic. So, what does it specifically do to one's body?
00:43Our understanding is that the reason ketamine is so useful in treating mental disorders is
00:48because it adjusts the brain and the plasticity of the brain. So, when somebody has ketamine
00:54and we're talking about lower doses and are used recreationally, but when somebody has ketamine,
00:59their brain is able to adapt and learn and respond to talking therapy faster than it would
01:06without it. And we've seen ketamine transform the treatment of depression. What we want to see now
01:12is whether it can do the same with post-traumatic stress disorder.
01:15Tara, I mentioned that you're a former emergency worker. Why does your former profession particularly need
01:23this sort of help? Thank you, Lorna. I mean, I think it's just really, over many years,
01:28I was an operational firefighter for 20 years and just noticing the impacts on myself when I would
01:33turn out to jobs and have a really visceral response to it and reaction and how long it took me
01:38to recover
01:39and the need to be able to access treatment that actually worked and met my needs and understood
01:44my world. And then seeing that in other emergency service workers and in my colleagues and the impact of
01:49those cumulative events over time and not being able to access treatment that actually worked or
01:55accessing treatment that wasn't effective. And so I think having an alternative to that is so
02:00important and something that's well researched and evidence-based. There's a huge need for it.
02:05Did you, when you first heard of this and before you'd researched it, see the word ketamine and think,
02:10goodness me. I think there's, you know, a little bit of mistrust amongst emergency service workers
02:18of new things. And I think that's why, you know, having somewhere like Black Dog Institute that really
02:22is evidence-based and there's rigorous ethical requirements and safety and support during, you know,
02:28any trial for a new drug, I think that really supports people to have trust in a new trial and
02:33go,
02:33OK, it's going to be OK. And a willingness to explore that because I think so people are so desperate
02:39to
02:39have something that enables them to reclaim their lives.
02:42Professor Harvey, so how will this work? Who will be chosen to trial it? And what is the process?
02:49So initially what we're going to be looking for is emergency service workers who have tried standard
02:55treatment where that hasn't helped their symptoms reduce. And then we'll use this as a second line
03:01treatment for them. And what's at the heart of this is a fundamental shift in our understanding of what
03:08we're doing when we're treating mental disorders like PTSD. We're not just adjusting chemicals to mask symptoms,
03:14we're allowing the brain to adapt and learn and change, which enables recovery. And so it's a combination
03:21of the medication together with the talking therapy, which we hope is going to make the real difference.
03:28Tara, looking forward, I mean, presumably it can be rolled out elsewhere. And I know you work in the
03:35mental health space. What are you hoping for?
03:39I mean, I hope obviously that we find that this new treatment is effective and that there is support
03:44and funding to enable us to access the people that really need it throughout the emergency services.
03:52And I think that speaks to both volunteer and paid. And we know there's a huge number of people out
03:56there. So I really hope it enables people to have access to treatment that works, that perhaps they've
04:02had access to other treatment that hasn't been effective. So that's really what I hope will come from it.

Recommended